Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Opiant Pharmaceuticals stock
Learn how to easily invest in Opiant Pharmaceuticals stock.
Opiant Pharmaceuticals Inc is a biotechnology business based in the US. Opiant Pharmaceuticals shares (OPNT) are listed on the NASDAQ and all prices are listed in US Dollars. Opiant Pharmaceuticals employs 37 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Opiant Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – OPNT – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Opiant Pharmaceuticals stock price (NASDAQ: OPNT)Use our graph to track the performance of OPNT stocks over time.
Opiant Pharmaceuticals shares at a glance
|Latest market close||$11.85|
|52-week range||$7.34 - $37.71|
|50-day moving average||$14.72|
|200-day moving average||$23.58|
|Wall St. target price||$40.25|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.37|
Buy Opiant Pharmaceuticals shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Opiant Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Opiant Pharmaceuticals price performance over time
|1 week (2022-06-30)||-1.17%|
|1 month (2022-06-07)||-7.42%|
|3 months (2022-04-06)||-44.70%|
|6 months (2022-01-06)||-63.14%|
|1 year (2021-07-07)||-26.49%|
|2 years (2020-07-07)||29.51%|
|3 years (2019-07-05)||13.48|
|5 years (2017-07-07)||87.17%|
Opiant Pharmaceuticals financials
|Revenue TTM||$45.9 million|
|Gross profit TTM||$21.9 million|
|Return on assets TTM||-4.52%|
|Return on equity TTM||-17.3%|
|Market capitalisation||$60.8 million|
TTM: trailing 12 months
Opiant Pharmaceuticals share dividends
We're not expecting Opiant Pharmaceuticals to pay a dividend over the next 12 months.
Have Opiant Pharmaceuticals's shares ever split?
Opiant Pharmaceuticals's shares were split on a 1:100 basis on 30 December 2014. So if you had owned 100 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Opiant Pharmaceuticals shares – just the quantity. However, indirectly, the new 9900% higher share price could have impacted the market appetite for Opiant Pharmaceuticals shares which in turn could have impacted Opiant Pharmaceuticals's share price.
Opiant Pharmaceuticals share price volatility
Over the last 12 months, Opiant Pharmaceuticals's shares have ranged in value from as little as $7.34 up to $37.71. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Opiant Pharmaceuticals's is 0.667. This would suggest that Opiant Pharmaceuticals's shares are less volatile than average (for this exchange).
Opiant Pharmaceuticals overview
Opiant Pharmaceuticals, Inc. , a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and changed its name to Opiant Pharmaceuticals, Inc. in January 2016.
Opiant Pharmaceuticals in the news
Opiant Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Opiant Pharmaceuticals and Aptar Pharma Expand Long-Term Collaboration for the Manufacture of Unidose Nasal Spray for OPNT003, Nasal Nalmefene
Frequently asked questionsWhat percentage of Opiant Pharmaceuticals is owned by insiders or institutions?
Currently 6.889% of Opiant Pharmaceuticals shares are held by insiders and 33.593% by institutions. How many people work for Opiant Pharmaceuticals?
Latest data suggests 37 work at Opiant Pharmaceuticals. When does the fiscal year end for Opiant Pharmaceuticals?
Opiant Pharmaceuticals's fiscal year ends in July. Where is Opiant Pharmaceuticals based?
Opiant Pharmaceuticals's address is: 233 Wilshirre Boulevard, Santa Monica, CA, United States, 90401 What is Opiant Pharmaceuticals's ISIN number?
Opiant Pharmaceuticals's international securities identification number is: US6837501039 What is Opiant Pharmaceuticals's CUSIP number?
Opiant Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 53224T105
More guides on Finder
How to buy Citrine Global (CTGL) stock when it goes public
Everything we know about the Citrine Global IPO, plus information on how to buy in.
How to buy Genelux Corporation (GNLX) stock when it goes public
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
How to buy Magic Empire Global (MEGL) stock when it goes public
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Ask an Expert